-
C.
Mah,
Z.
Nassar,
J.
Swinnen,
L.
Butler
(2019)
Lipogenic effects of androgen signaling in normal and malignant prostate
Asian Journal of Urology, 7
-
(
ShuklaN
AdhyaAK
RathJ
. Expression of alpha-methylacyl-coenzyme A racemase (AMACR) in colorectal neoplasia. J Clin Diagn Res. 2017;11:EC35-EC38.)
ShuklaN
AdhyaAK
RathJ
. Expression of alpha-methylacyl-coenzyme A racemase (AMACR) in colorectal neoplasia. J Clin Diagn Res. 2017;11:EC35-EC38.
ShuklaN
AdhyaAK
RathJ
. Expression of alpha-methylacyl-coenzyme A racemase (AMACR) in colorectal neoplasia. J Clin Diagn Res. 2017;11:EC35-EC38.,
ShuklaN
AdhyaAK
RathJ
. Expression of alpha-methylacyl-coenzyme A racemase (AMACR) in colorectal neoplasia. J Clin Diagn Res. 2017;11:EC35-EC38.
-
(
TawficS
NiehansGA
ManivelJC
. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Hum Pathol. 2003;34:450-456. doi:10.1016/S0046-8177(03)00077-7.12792918)
TawficS
NiehansGA
ManivelJC
. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Hum Pathol. 2003;34:450-456. doi:10.1016/S0046-8177(03)00077-7.12792918
TawficS
NiehansGA
ManivelJC
. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Hum Pathol. 2003;34:450-456. doi:10.1016/S0046-8177(03)00077-7.12792918,
TawficS
NiehansGA
ManivelJC
. The pattern of CD10 expression in selected pathologic entities of the prostate gland. Hum Pathol. 2003;34:450-456. doi:10.1016/S0046-8177(03)00077-7.12792918
-
(
AndrewsC
HumphreyPA
. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol. 2014;38:1007-1012.24705308)
AndrewsC
HumphreyPA
. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol. 2014;38:1007-1012.24705308
AndrewsC
HumphreyPA
. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol. 2014;38:1007-1012.24705308,
AndrewsC
HumphreyPA
. Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue. Am J Surg Pathol. 2014;38:1007-1012.24705308
-
A.
Hoogland,
C.
Kweldam,
G.
Leenders
(2014)
Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
BioMed Research International, 2014
-
(2002)
Understanding p 27 kip 1 deregulation in cancer : down - regulation or mislocalization ?
-
(
EpsteinJI
EgevadL
AminMB
, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244-252.26492179)
EpsteinJI
EgevadL
AminMB
, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244-252.26492179
EpsteinJI
EgevadL
AminMB
, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244-252.26492179,
EpsteinJI
EgevadL
AminMB
, et al. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244-252.26492179
-
D.
Mishra,
Sunita
Singh,
G.
Narayan
(2016)
Role of B Cell Development Marker CD10 in Cancer Progression and Prognosis
Molecular Biology International, 2016
-
M.
Farinola,
J.
Epstein
(2004)
Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.
Human pathology, 35 10
-
(2008)
Characterization of TMPRSS2ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications
-
(
WangS
ZhangQ
XuD
, et al. Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer. Gene. 2018;679:186-194.30195632)
WangS
ZhangQ
XuD
, et al. Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer. Gene. 2018;679:186-194.30195632
WangS
ZhangQ
XuD
, et al. Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer. Gene. 2018;679:186-194.30195632,
WangS
ZhangQ
XuD
, et al. Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer. Gene. 2018;679:186-194.30195632
-
(
FarinolaMA
EpsteinJI
. Utility of immunohistochemistry for alpha- methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.15492996)
FarinolaMA
EpsteinJI
. Utility of immunohistochemistry for alpha- methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.15492996
FarinolaMA
EpsteinJI
. Utility of immunohistochemistry for alpha- methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.15492996,
FarinolaMA
EpsteinJI
. Utility of immunohistochemistry for alpha- methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol. 2004;35:1272-1278.15492996
-
(
DarnelAD
LafargueCJ
VollmerRT
CorcosJ
BismarTA
. TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther. 2009;8:125-130.19029822)
DarnelAD
LafargueCJ
VollmerRT
CorcosJ
BismarTA
. TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther. 2009;8:125-130.19029822
DarnelAD
LafargueCJ
VollmerRT
CorcosJ
BismarTA
. TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther. 2009;8:125-130.19029822,
DarnelAD
LafargueCJ
VollmerRT
CorcosJ
BismarTA
. TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther. 2009;8:125-130.19029822
-
A.
Nassif,
Renato
Filho
(2010)
Immunohistochemistry expression of tumor markers CD34 and P27 as a prognostic factor of clinically localized prostate adenocarcinoma after radical prostatectomy.
Revista do Colegio Brasileiro de Cirurgioes, 37 5
-
V.
Kulda,
O.
Topolcan,
R.
Kučera,
M.
Kripnerová,
Kristýna
Srbecká,
M.
Hora,
O.
Hes,
J.
Klečka,
V.
Babuška,
M.
Roušarová,
V.
Benson,
M.
Pešta
(2016)
Prognostic Significance of TMPRSS2-ERG Fusion Gene in Prostate Cancer.
Anticancer research, 36 9
-
(
LeeSL
YuD
WangC
, et al. ERG Expression in prostate needle biopsy: potential diagnostic and prognostic implications. Appl Immunohistochem Mol Morphol. 2015;23:499-505.25517865)
LeeSL
YuD
WangC
, et al. ERG Expression in prostate needle biopsy: potential diagnostic and prognostic implications. Appl Immunohistochem Mol Morphol. 2015;23:499-505.25517865
LeeSL
YuD
WangC
, et al. ERG Expression in prostate needle biopsy: potential diagnostic and prognostic implications. Appl Immunohistochem Mol Morphol. 2015;23:499-505.25517865,
LeeSL
YuD
WangC
, et al. ERG Expression in prostate needle biopsy: potential diagnostic and prognostic implications. Appl Immunohistochem Mol Morphol. 2015;23:499-505.25517865
-
The pattern of CD10 expression in selected pathologic entities of the prostate gland
-
Srirupa
Roy,
R.
Singh,
C.
Agarwal,
S.
Siriwardana,
R.
Sclafani,
R.
Agarwal
(2008)
Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype
Cell Cycle, 7
-
(
VlachostergiosPJ
KarasavvidouF
KakkasG
, et al. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer. J Negat Results Biomed. 2012;11:2.22221586)
VlachostergiosPJ
KarasavvidouF
KakkasG
, et al. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer. J Negat Results Biomed. 2012;11:2.22221586
VlachostergiosPJ
KarasavvidouF
KakkasG
, et al. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer. J Negat Results Biomed. 2012;11:2.22221586,
VlachostergiosPJ
KarasavvidouF
KakkasG
, et al. Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer. J Negat Results Biomed. 2012;11:2.22221586
-
(
RevelosK
PetrakiC
GregorakisA
, et al. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In Vivo. 2005;19:911-920.16097446)
RevelosK
PetrakiC
GregorakisA
, et al. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In Vivo. 2005;19:911-920.16097446
RevelosK
PetrakiC
GregorakisA
, et al. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In Vivo. 2005;19:911-920.16097446,
RevelosK
PetrakiC
GregorakisA
, et al. p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer. In Vivo. 2005;19:911-920.16097446
-
Shira
Ronen,
Daniel
Abbott,
O.
Kravtsov,
A.
Abdelkader,
Yayun
Xu,
A.
Banerjee,
K.
Iczkowski
(2017)
PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
Human pathology, 65
-
احمد
شلبی,
اسامه
کریم,
سیدعلی
احمدی
(2008)
مارکر P504S در تشخیص پرولیفراسیون غددی آتیپیک پروستات
, 66
-
M.
Dall’Era,
L.
True,
A.
Siegel,
M.
Porter,
T.
Sherertz,
Alvin
Liu
(2007)
Differential expression of CD10 in prostate cancer and its clinical implication
BMC Urology, 7
-
(
KaurM
VermaS
GuptaR
PantL
SinghS
. CD10 expression pattern in prostatic adenocarcinoma: elucidation of differences between Gleason’s grades. Malays J Pathol. 2018;40:57-60.29704385)
KaurM
VermaS
GuptaR
PantL
SinghS
. CD10 expression pattern in prostatic adenocarcinoma: elucidation of differences between Gleason’s grades. Malays J Pathol. 2018;40:57-60.29704385
KaurM
VermaS
GuptaR
PantL
SinghS
. CD10 expression pattern in prostatic adenocarcinoma: elucidation of differences between Gleason’s grades. Malays J Pathol. 2018;40:57-60.29704385,
KaurM
VermaS
GuptaR
PantL
SinghS
. CD10 expression pattern in prostatic adenocarcinoma: elucidation of differences between Gleason’s grades. Malays J Pathol. 2018;40:57-60.29704385
-
A.
Murphy,
C.
Hughes,
G.
Lannigan,
O.
Sheils,
J.
O'Leary,
B.
Loftus
(2007)
Heterogeneous expression of α‐methylacyl‐CoA racemase in prostatic cancer correlates with Gleason score
Histopathology, 50
-
(2007)
Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Histopathology
-
(
FreedlandSJ
SeligsonDB
LiuAY
, et al. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003;55:71-80.12640663)
FreedlandSJ
SeligsonDB
LiuAY
, et al. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003;55:71-80.12640663
FreedlandSJ
SeligsonDB
LiuAY
, et al. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003;55:71-80.12640663,
FreedlandSJ
SeligsonDB
LiuAY
, et al. Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer. Prostate. 2003;55:71-80.12640663
-
(
MishraD
SinghS
NarayanG
. Role of B cell development marker CD10 in cancer progression and prognosis. Mol Biol Int. 2016;2016:4328697.27965895)
MishraD
SinghS
NarayanG
. Role of B cell development marker CD10 in cancer progression and prognosis. Mol Biol Int. 2016;2016:4328697.27965895
MishraD
SinghS
NarayanG
. Role of B cell development marker CD10 in cancer progression and prognosis. Mol Biol Int. 2016;2016:4328697.27965895,
MishraD
SinghS
NarayanG
. Role of B cell development marker CD10 in cancer progression and prognosis. Mol Biol Int. 2016;2016:4328697.27965895
-
N.
Shukla,
A.
Adhya,
Jaysree
Rath
(2017)
Expression of Alpha - Methylacyl - Coenzyme A Racemase (AMACR) in Colorectal Neoplasia.
Journal of clinical and diagnostic research : JCDR, 11 4
-
C.
Andrews,
P.
Humphrey
(2014)
Utility of ERG Versus AMACR Expression in Diagnosis of Minimal Adenocarcinoma of the Prostate in Needle Biopsy Tissue
The American Journal of Surgical Pathology, 38
-
S.
Freedland,
D.
Seligson,
Alvin
Liu,
A.
Pantuck,
S.
Paik,
S.
Horvath,
J.
Wieder,
A.
Zisman,
David
Nguyen,
C.
Tso,
A.
Palotie,
A.
Belldegrun
(2003)
Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer
The Prostate, 55
-
S.
Alinezhad,
R.
Väänänen,
Natalia
Ochoa,
E.
Vertosick,
A.
Bjartell,
P.
Boström,
P.
Taimen,
K.
Pettersson
(2016)
Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate
BMC Urology, 16
-
(
TomlinsSA
RhodesDR
PernerS
, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.16254181)
TomlinsSA
RhodesDR
PernerS
, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.16254181
TomlinsSA
RhodesDR
PernerS
, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.16254181,
TomlinsSA
RhodesDR
PernerS
, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644-648.16254181
-
M.
Rubin,
Ming
Zhou,
S.
Dhanasekaran,
S.
Varambally,
T.
Barrette,
M.
Sanda,
K.
Pienta,
D.
Ghosh,
A.
Chinnaiyan
(2002)
alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
JAMA, 287 13
-
Shiyuan
Wang,
Qi
Zhang,
Dandan
Xu,
Yi
Pan,
Y.
Lv,
Xiaowen
Chen,
Yongchun
Zuo,
Lei
Yang
(2018)
Characterize the difference between TMPRSS2-ERG and non-TMPRSS2-ERG fusion patients by clinical and biological characteristics in prostate cancer.
Gene, 679
-
(
Marije HooglandA
KweldamCF
Van LeendersGLJH
. Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. Nephrourol Mon. 2016;8:e41505.27933279)
Marije HooglandA
KweldamCF
Van LeendersGLJH
. Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. Nephrourol Mon. 2016;8:e41505.27933279
Marije HooglandA
KweldamCF
Van LeendersGLJH
. Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. Nephrourol Mon. 2016;8:e41505.27933279,
Marije HooglandA
KweldamCF
Van LeendersGLJH
. Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review. Nephrourol Mon. 2016;8:e41505.27933279
-
(
MosqueraJM
PernerS
GenegaEM
, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008;14:3380-3385.18519767)
MosqueraJM
PernerS
GenegaEM
, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008;14:3380-3385.18519767
MosqueraJM
PernerS
GenegaEM
, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008;14:3380-3385.18519767,
MosqueraJM
PernerS
GenegaEM
, et al. Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res. 2008;14:3380-3385.18519767
-
A.
Zlotta,
Epstein
Ji,
A.
Wc
(2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Glea- son Grading of Prostatic Carcinoma
-
(
RonenS
AbbottDW
KravtsovO
, et al. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. Hum Pathol. 2017;65:85-91.28504208)
RonenS
AbbottDW
KravtsovO
, et al. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. Hum Pathol. 2017;65:85-91.28504208
RonenS
AbbottDW
KravtsovO
, et al. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. Hum Pathol. 2017;65:85-91.28504208,
RonenS
AbbottDW
KravtsovO
, et al. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform. Hum Pathol. 2017;65:85-91.28504208
-
J.
Epstein,
L.
Egevad,
M.
Amin,
B.
Delahunt,
J.
Srigley,
P.
Humphrey
(2015)
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System
The American Journal of Surgical Pathology, 40
-
(
RoyS
SinghRP
AgarwalC
SiriwardanaS
SclafaniR
AgarwalR
. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle. 2008;7:1828-1835.18583941)
RoyS
SinghRP
AgarwalC
SiriwardanaS
SclafaniR
AgarwalR
. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle. 2008;7:1828-1835.18583941
RoyS
SinghRP
AgarwalC
SiriwardanaS
SclafaniR
AgarwalR
. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle. 2008;7:1828-1835.18583941,
RoyS
SinghRP
AgarwalC
SiriwardanaS
SclafaniR
AgarwalR
. Downregulation of both p21/Cip1 and p27/Kip1 produces a more aggressive prostate cancer phenotype. Cell Cycle. 2008;7:1828-1835.18583941
-
Zhu
Wang,
Yuliang
Wang,
Jian-wen
Zhang,
Qi-yi
Hu,
Fan
Zhi,
Sheng-ping
Zhang,
D.
Mao,
Ying
Zhang,
Hui
Liang
(2017)
Significance of the TMPRSS2:ERG gene fusion in prostate cancer
Molecular Medicine Reports, 16
-
J.
Mosquera,
S.
Perner,
E.
Genega,
M.
Sanda,
M.
Hofer,
K.
Mertz,
P.
Paris,
J.
Simko,
T.
Bismar,
G.
Ayala,
R.
Shah,
M.
Loda,
M.
Rubin
(2008)
Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
Clinical Cancer Research, 14
-
S.
Tawfic,
G.
Niehans,
J.
Manivel
(2003)
The pattern of CD10 expression in selected pathologic entities of the prostate gland.
Human pathology, 34 5
-
K.
Revelos,
C.
Petraki,
A.
Gregorakis,
A.
Scorilas,
P.
Papanastasiou,
R.
Tenta,
M.
Koutsilieris
(2005)
p27(kip1) and Ki-67 (MIB1) immunohistochemical expression in radical prostatectomy specimens of patients with clinically localized prostate cancer.
In vivo, 19 5
-
(
KuldaV
TopolcanO
KuceraR
, et al. Prognostic significance of TMPRSS2-ERG fusion gene in prostate cancer. Anticancer Res. 2016;36:4787-4793.27630329)
KuldaV
TopolcanO
KuceraR
, et al. Prognostic significance of TMPRSS2-ERG fusion gene in prostate cancer. Anticancer Res. 2016;36:4787-4793.27630329
KuldaV
TopolcanO
KuceraR
, et al. Prognostic significance of TMPRSS2-ERG fusion gene in prostate cancer. Anticancer Res. 2016;36:4787-4793.27630329,
KuldaV
TopolcanO
KuceraR
, et al. Prognostic significance of TMPRSS2-ERG fusion gene in prostate cancer. Anticancer Res. 2016;36:4787-4793.27630329
-
(
VigliettoG
FuscoA
. Understanding p27kip1 deregulation in cancer: down-regulation or mislocalization?
Cell Cycle. 2002;1:394-400.12548012)
VigliettoG
FuscoA
. Understanding p27kip1 deregulation in cancer: down-regulation or mislocalization?
Cell Cycle. 2002;1:394-400.12548012
VigliettoG
FuscoA
. Understanding p27kip1 deregulation in cancer: down-regulation or mislocalization?
Cell Cycle. 2002;1:394-400.12548012,
VigliettoG
FuscoA
. Understanding p27kip1 deregulation in cancer: down-regulation or mislocalization?
Cell Cycle. 2002;1:394-400.12548012
-
(
ThomasGV
SchrageMI
RosenfeltL
, et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol. 2000;164:1987-1991.11061897)
ThomasGV
SchrageMI
RosenfeltL
, et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol. 2000;164:1987-1991.11061897
ThomasGV
SchrageMI
RosenfeltL
, et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol. 2000;164:1987-1991.11061897,
ThomasGV
SchrageMI
RosenfeltL
, et al. Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage. J Urol. 2000;164:1987-1991.11061897
-
(
EderIE
BekticJ
HaagP
BartschG
KlockerH
. Genes differentially expressed in prostate cancer. BJU Int. 2004;93:1151-1155.15142130)
EderIE
BekticJ
HaagP
BartschG
KlockerH
. Genes differentially expressed in prostate cancer. BJU Int. 2004;93:1151-1155.15142130
EderIE
BekticJ
HaagP
BartschG
KlockerH
. Genes differentially expressed in prostate cancer. BJU Int. 2004;93:1151-1155.15142130,
EderIE
BekticJ
HaagP
BartschG
KlockerH
. Genes differentially expressed in prostate cancer. BJU Int. 2004;93:1151-1155.15142130
-
Alba
Font-Tello,
N.
Juanpere,
S.
Muga,
M.
Lorenzo,
J.
Lorente,
L.
Fumadó,
L.
Serrano,
S.
Serrano,
J.
Lloreta,
S.
Hernández
(2015)
Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels
The Prostate, 75
-
(
Dall‘EraMA
TrueLD
SiegelAF
PorterMP
SherertzTM
LiuAY
. Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol. 2007;7:3.17335564)
Dall‘EraMA
TrueLD
SiegelAF
PorterMP
SherertzTM
LiuAY
. Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol. 2007;7:3.17335564
Dall‘EraMA
TrueLD
SiegelAF
PorterMP
SherertzTM
LiuAY
. Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol. 2007;7:3.17335564,
Dall‘EraMA
TrueLD
SiegelAF
PorterMP
SherertzTM
LiuAY
. Differential expression of CD10 in prostate cancer and its clinical implication. BMC Urol. 2007;7:3.17335564
-
(
NassifAE
Tâmbara FilhoR
. Immunohistochemistry expression of tumor markers CD34 and P27 as a prognostic factor of clinically localized prostate adenocarcinoma after radical prostatectomy. Rev Col Bras Cir. 2010;37:338-344.21180999)
NassifAE
Tâmbara FilhoR
. Immunohistochemistry expression of tumor markers CD34 and P27 as a prognostic factor of clinically localized prostate adenocarcinoma after radical prostatectomy. Rev Col Bras Cir. 2010;37:338-344.21180999
NassifAE
Tâmbara FilhoR
. Immunohistochemistry expression of tumor markers CD34 and P27 as a prognostic factor of clinically localized prostate adenocarcinoma after radical prostatectomy. Rev Col Bras Cir. 2010;37:338-344.21180999,
NassifAE
Tâmbara FilhoR
. Immunohistochemistry expression of tumor markers CD34 and P27 as a prognostic factor of clinically localized prostate adenocarcinoma after radical prostatectomy. Rev Col Bras Cir. 2010;37:338-344.21180999
-
C.
Hägglöf,
Peter
Hammarsten,
Kerstin
Strömvall,
L.
Egevad,
A.
Josefsson,
P.
Stattin,
T.
Granfors,
A.
Bergh
(2014)
TMPRSS2-ERG Expression Predicts Prostate Cancer Survival and Associates with Stromal Biomarkers
PLoS ONE, 9
-
G.
Viglietto,
M.
Motti,
Alfredo
Fresco
(2002)
Understanding p27kip1 Deregulation in Cancer: Downregulation or Mislocalizaiton?
Cell Cycle, 1
-
(
ZhangZ
RosenDG
YaoJL
HuangJ
LiuJ
. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol. 2006;19:1339-1343.16799475)
ZhangZ
RosenDG
YaoJL
HuangJ
LiuJ
. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol. 2006;19:1339-1343.16799475
ZhangZ
RosenDG
YaoJL
HuangJ
LiuJ
. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol. 2006;19:1339-1343.16799475,
ZhangZ
RosenDG
YaoJL
HuangJ
LiuJ
. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression. Mod Pathol. 2006;19:1339-1343.16799475
-
Sandra
Lee,
Darryl
Yu,
Cheng
Wang,
Raya
Saba,
Shuhong
Liu,
K.
Trpkov,
B.
Donnelly,
T.
Bismar
(2015)
ERG Expression in Prostate Needle Biopsy: Potential Diagnostic and Prognostic Implications
Applied Immunohistochemistry & Molecular Morphology, 23
-
(
HägglöfC
HammarstenP
StrömvallK
, et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS ONE. 2014;9:e86824.24505269)
HägglöfC
HammarstenP
StrömvallK
, et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS ONE. 2014;9:e86824.24505269
HägglöfC
HammarstenP
StrömvallK
, et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS ONE. 2014;9:e86824.24505269,
HägglöfC
HammarstenP
StrömvallK
, et al. TMPRSS2-ERG expression predicts prostate cancer survival and associates with stromal biomarkers. PLoS ONE. 2014;9:e86824.24505269
-
A.
Darnel,
C.
LaFargue,
R.
Vollmer,
J.
Corcos,
T.
Bismar
(2009)
TMPRSS2-ERG fusion is frequently observed in gleason pattern 3 prostate cancer in a Canadian cohort
Cancer Biology & Therapy, 8
-
(
FineSW
GopalanA
LevershaMA
, et al. TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. Mod Pathol. 2010;23:1325-1333.20562851)
FineSW
GopalanA
LevershaMA
, et al. TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. Mod Pathol. 2010;23:1325-1333.20562851
FineSW
GopalanA
LevershaMA
, et al. TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. Mod Pathol. 2010;23:1325-1333.20562851,
FineSW
GopalanA
LevershaMA
, et al. TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features. Mod Pathol. 2010;23:1325-1333.20562851
-
Zhongbe
Jiang,
B.
Woda,
K.
Rock,
Yingdan
Xu,
L.
Savas,
Ashraf
Khan,
G.
Pihan,
F.
Cai,
J.
Babcook,
P.
Rathanaswami,
S.
Reed,
Jiangchun
Xu,
G.
Fanger
(2001)
P504S: A New Molecular Marker for the Detection of Prostate Carcinoma
The American Journal of Surgical Pathology, 25
-
(2016)
Prognostic significance of TMPRSS2ERG fusion gene in prostate cancer
-
(
SirmaH
BroemelM
StummL
, et al. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6:1245-1252.24179503)
SirmaH
BroemelM
StummL
, et al. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6:1245-1252.24179503
SirmaH
BroemelM
StummL
, et al. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6:1245-1252.24179503,
SirmaH
BroemelM
StummL
, et al. Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis. Oncol Lett. 2013;6:1245-1252.24179503
-
A.
Vis,
B.
Rhijn,
M.
Noordzij,
F.
Schröder,
T.
Kwast
(2002)
Value of tissue markers p27kip1, MIB‐1, and CD44s for the pre‐operative prediction of tumour features in screen‐detected prostate cancer
The Journal of Pathology, 197
-
(
MahCY
NassarZD
SwinnenJV
ButlerLM
. Lipogenic effects of androgen signaling in normal and malignant prostate [published online ahead of print December 10, 2019]. Asian J Urol. doi:10.1016/j.ajur.2019.12.003.)
MahCY
NassarZD
SwinnenJV
ButlerLM
. Lipogenic effects of androgen signaling in normal and malignant prostate [published online ahead of print December 10, 2019]. Asian J Urol. doi:10.1016/j.ajur.2019.12.003.
MahCY
NassarZD
SwinnenJV
ButlerLM
. Lipogenic effects of androgen signaling in normal and malignant prostate [published online ahead of print December 10, 2019]. Asian J Urol. doi:10.1016/j.ajur.2019.12.003.,
MahCY
NassarZD
SwinnenJV
ButlerLM
. Lipogenic effects of androgen signaling in normal and malignant prostate [published online ahead of print December 10, 2019]. Asian J Urol. doi:10.1016/j.ajur.2019.12.003.
-
(
LiuW
. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer. Asian J Androl. 2016;18:533-542.26975494)
LiuW
. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer. Asian J Androl. 2016;18:533-542.26975494
LiuW
. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer. Asian J Androl. 2016;18:533-542.26975494,
LiuW
. DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer. Asian J Androl. 2016;18:533-542.26975494
-
Ling
Nie,
J.
Gong,
Xue-qin
Chen,
Miao
Xu,
Qiao
Zhou,
Ni
Chen
(2019)
The Prostate
-
(
NieL
PanX
ZhangM
, et al. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center. Prostate. 2019;79:819-825.30900303)
NieL
PanX
ZhangM
, et al. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center. Prostate. 2019;79:819-825.30900303
NieL
PanX
ZhangM
, et al. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center. Prostate. 2019;79:819-825.30900303,
NieL
PanX
ZhangM
, et al. The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center. Prostate. 2019;79:819-825.30900303
-
Wennuan
Liu
(2016)
DNA alterations in the tumor genome and their associations with clinical outcome in prostate cancer
Asian Journal of Andrology, 18
-
(
VisAN
van RhijnBW
NoordzijMA
SchröderFH
van der KwastTH
. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen- detected prostate cancer. J Pathol. 2002;197:148-154.12015737)
VisAN
van RhijnBW
NoordzijMA
SchröderFH
van der KwastTH
. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen- detected prostate cancer. J Pathol. 2002;197:148-154.12015737
VisAN
van RhijnBW
NoordzijMA
SchröderFH
van der KwastTH
. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen- detected prostate cancer. J Pathol. 2002;197:148-154.12015737,
VisAN
van RhijnBW
NoordzijMA
SchröderFH
van der KwastTH
. Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen- detected prostate cancer. J Pathol. 2002;197:148-154.12015737
-
Loss of CD 10 ( neutral endopeptidase ) is a frequent and early event in human
-
S.
Tomlins,
D.
Rhodes,
S.
Perner,
S.
Dhanasekaran,
R.
Mehra,
Xiao-wei
Sun,
S.
Varambally,
Xuhong
Cao,
J.
Tchinda,
R.
Kuefer,
Charles
Lee,
J.
Montie,
R.
Shah,
K.
Pienta,
M.
Rubin,
A.
Chinnaiyan
(2005)
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Science, 310
-
(
MurphyAJ
HughesCA
LanniganG
SheilsO
O’LearyJ
LoftusB
. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Histopathology. 2007;50:243-251.17222253)
MurphyAJ
HughesCA
LanniganG
SheilsO
O’LearyJ
LoftusB
. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Histopathology. 2007;50:243-251.17222253
MurphyAJ
HughesCA
LanniganG
SheilsO
O’LearyJ
LoftusB
. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Histopathology. 2007;50:243-251.17222253,
MurphyAJ
HughesCA
LanniganG
SheilsO
O’LearyJ
LoftusB
. Heterogeneous expression of alpha-methylacyl-CoA racemase in prostatic cancer correlates with Gleason score. Histopathology. 2007;50:243-251.17222253
-
The expression profile and heterogeneity analysis of ERG in 633 consecutive prostate cancers from a single center
-
P.
Vlachostergios,
F.
Karasavvidou,
Grigorios
Kakkas,
K.
Kapatou,
I.
Gioulbasanis,
D.
Daliani,
G.
Moutzouris,
C.
Papandreou
(2012)
Lack of prognostic significance of p16 and p27 after radical prostatectomy in hormone-naïve prostate cancer
Journal of Negative Results in Biomedicine, 11
-
(
AlinezhadS
VäänänenRM
OchoaNT
, et al. Global expression of AMACR transcripts predicts risk for prostate cancer − a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. BMC Urol. 2016;16:10.26928323)
AlinezhadS
VäänänenRM
OchoaNT
, et al. Global expression of AMACR transcripts predicts risk for prostate cancer − a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. BMC Urol. 2016;16:10.26928323
AlinezhadS
VäänänenRM
OchoaNT
, et al. Global expression of AMACR transcripts predicts risk for prostate cancer − a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. BMC Urol. 2016;16:10.26928323,
AlinezhadS
VäänänenRM
OchoaNT
, et al. Global expression of AMACR transcripts predicts risk for prostate cancer − a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate. BMC Urol. 2016;16:10.26928323
-
H.
Sirma,
Margarethe
Broemel,
Laura
Stumm,
Tina
Tsourlakis,
S.
Steurer,
P.
Tennstedt,
G.
Salomon,
U.
Michl,
A.
Haese*,
R.
Simon,
G.
Sauter,
T.
Schlomm,
S.
Minner
(2013)
Loss of CDKN1B/p27Kip1 expression is associated with ERG fusion-negative prostate cancer, but is unrelated to patient prognosis
Oncology Letters, 6
-
I.
Eder,
J.
Bektic,
P.
Hååg,
G.
Bartsch,
H.
Klocker
(2004)
Genes differentially expressed in prostate cancer
BJU International, 93
-
S.
Fine,
A.
Gopalan,
M.
Leversha,
H.
Al-Ahmadie,
S.
Tickoo,
Qin
Zhou,
J.
Satagopan,
P.
Scardino,
W.
Gerald,
V.
Reuter
(2010)
TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
Modern Pathology, 23
-
G.
Thomas,
M.
Schrage,
L.
Rosenfelt,
J.
Kim,
G.
Salur,
J.
Dekernion,
F.
Dorey,
J.
Said,
R.
Reiter
(2000)
Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, Gleason grade and pathological stage.
The Journal of urology, 164 6
-
(
JiangZ
WodaBA
RockKL
, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.11684956)
JiangZ
WodaBA
RockKL
, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.11684956
JiangZ
WodaBA
RockKL
, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.11684956,
JiangZ
WodaBA
RockKL
, et al. P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1397-1404.11684956
-
Lipogenic effects of androgen signaling in normal and malignant prostate [published online ahead of print December 10, 2019]
-
M.
Kaur,
S.
Verma,
R.
Gupta,
L.
Pant,
S.
Singh
(2018)
CD10 expression pattern in prostatic adenocarcinoma: Elucidation of differences between Gleason's grades.
The Malaysian journal of pathology, 40 1
-
Zhihong
Zhang,
D.
Rosen,
Jorge
Yao,
Jiaoti
Huang,
Jinsong
Liu
(2006)
Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression
Modern Pathology, 19
-
(
WangZ
WangY
ZhangJ
, et al. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. Mol Med Rep. 2017;16:5450-5458.28849022)
WangZ
WangY
ZhangJ
, et al. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. Mol Med Rep. 2017;16:5450-5458.28849022
WangZ
WangY
ZhangJ
, et al. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. Mol Med Rep. 2017;16:5450-5458.28849022,
WangZ
WangY
ZhangJ
, et al. Significance of the TMPRSS2:ERG gene fusion in prostate cancer. Mol Med Rep. 2017;16:5450-5458.28849022
-
(
RubinMA
ZhouM
DhanasekaranSM
, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.11926890)
RubinMA
ZhouM
DhanasekaranSM
, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.11926890
RubinMA
ZhouM
DhanasekaranSM
, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.11926890,
RubinMA
ZhouM
DhanasekaranSM
, et al. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662-1670.11926890
-
(2002)
Understanding p27kip1 deregulation in cancer: downregulation or mislocalization? Cell Cycle
-
(
Font-TelloA
JuanpereN
de MugaS
, et al. Association of ERG and TMPRSS2- ERG with grade, stage and prognosis of prostate cancer is dependent on their expression levels. Prostate. 2015;75:1216-1226.25939480)
Font-TelloA
JuanpereN
de MugaS
, et al. Association of ERG and TMPRSS2- ERG with grade, stage and prognosis of prostate cancer is dependent on their expression levels. Prostate. 2015;75:1216-1226.25939480
Font-TelloA
JuanpereN
de MugaS
, et al. Association of ERG and TMPRSS2- ERG with grade, stage and prognosis of prostate cancer is dependent on their expression levels. Prostate. 2015;75:1216-1226.25939480,
Font-TelloA
JuanpereN
de MugaS
, et al. Association of ERG and TMPRSS2- ERG with grade, stage and prognosis of prostate cancer is dependent on their expression levels. Prostate. 2015;75:1216-1226.25939480